Glibornuride

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Glibornuride (INN) is an anti-diabetic drug from the group of sulfonylureas.^[1]

References

↑ Haupt E, Köberich W, Beyer J, Schöffling K (December 1971). “Pharmacodynamic aspects of tolbutamide, glibenclamide, glibornuride and glisoxepide. I. Dose response relations and repeated administration in diabetic subjects”. Diabetologia. 7 (6): 449–54. doi:10.1007/bf01212061. PMID 5004178.

Overview